INAB

NASDAQStock

IN8bio, Inc.

$1.90-0.01 (-0.53%)

52-Week Range

$1.21

$7.08

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

0.00

Volume

57.3K

Avg Volume

36.0K

Performance

+3.24%

+19.37%

-4.50%

YTD

-22.36%

-71.75%

-95.21%

-99.36%

Price Chart

ETF Exposure

INAB is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	0	$0	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	0	$0	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	0	$0	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	0	$0	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	0	$0	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	0	$0	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	19,475	$38K	$84.10B	0.05%

About INAB ETF Exposure

IN8bio, Inc. (INAB) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $1.90. Investors can gain exposure to INAB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold INAB, sorted by portfolio weight.